Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.

類似資料

• Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.
  著者:: Wang, D, 等
  出版事項: (2008)
• Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation
  著者:: Wang, D, 等
  出版事項: (2008)
• Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation
  著者:: D Wang, 等
  出版事項: (2008-12-01)
• Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: systematic review and additional economic modelling of subgroup analyses
  著者:: D Wang, 等
  出版事項: (2011-01-01)
• Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar
  著者:: Abushahin A, 等
  出版事項: (2018-01-01)